BGC945
thymidylate synthase inhibitor; structure in first source
Also Known As:
BGC 945; N-(4-(2-propyn-1-yl(4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-gamma-glutamylglutamic acid; N-(4-(2-propyn-1-yl(4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-l-gamma-glutamyl-d-glutamic acid; ONX 0801
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Jackman, Ann L:
2 articles
(05/2008 - 12/2005)
|
2. | Mitchell, Fraser:
2 articles
(05/2008 - 12/2005)
|
3. | Dalziel, Sean:
1 article
(07/2013)
|
4. | Eidam, Oliv:
1 article
(07/2013)
|
5. | Finer-Moore, Janet S:
1 article
(07/2013)
|
6. | Griner, Sarah:
1 article
(07/2013)
|
7. | O'Connell, Joseph D:
1 article
(07/2013)
|
8. | Stroud, Robert M:
1 article
(07/2013)
|
9. | Tochowicz, Anna:
1 article
(07/2013)
|
10. | Aboagye, Eric O:
1 article
(05/2008)
|
Related Diseases
Related Drugs and Biologics